Your browser doesn't support javascript.
loading
Letrozole for Female Infertility.
Yang, Ai-Min; Cui, Na; Sun, Yi-Fei; Hao, Gui-Min.
Afiliación
  • Yang AM; Department of Reproductive Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Cui N; Department of Reproductive Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Sun YF; Department of Reproductive Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Hao GM; Department of Reproductive Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Front Endocrinol (Lausanne) ; 12: 676133, 2021.
Article en En | MEDLINE | ID: mdl-34220713
Letrozole, an aromatase inhibitor that blocks estrogen synthesis by inhibiting the final step of the estrogen biosynthetic pathway, has been used in the applications of a wide range of infertility settings. It has been more than 20 years since the initial clinical trial of letrozole for ovulation induction. In light of the accumulating clinical and basic evidence, the efficacy and safety of letrozole have been identified. This mini review focuses on our current knowledge of the applications and mechanisms of letrozole for female infertility and various questions are put forward about how letrozole could be more effectively used.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de la Aromatasa / Letrozol / Infertilidad Femenina Límite: Female / Humans Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de la Aromatasa / Letrozol / Infertilidad Femenina Límite: Female / Humans Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza